SEC Form 4 · accession 0002068365-26-000005
Legend Biotech Corp · LEGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick John Casey
Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001801198
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jun 30, 2026 | S | 6,000 | $14.80 | D | 48,604 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
- F2The price reported in Column 4 represents the converted sales price of ADSs of $29.60 per ADS (which is equivalent to $14.80 per ordinary share).